At the University clinic of Tbilisi used a new ultra-fast us test the system

2020/05/56406-1588322038.jpg
Read: 1209     11:00     01 Май 2020    

The first University clinic in Tbilisi uses new American test systems "GeneXpert" (GeneXpert), the release of which in mid-March was approved by the us food and drug Administration (FDA). GeneExpert test systems are the latest devices for detecting coronavirus within 45 minutes of preparing a sample for analysis. The technology was developed by the California - based company Cepheid. You don't need special training to work with this test system-you only need access to the Cepheid GeneXpert system to process the test results.

The US authorities are confident that the production of such tests is an important step in the fight against the pandemic and are establishing their in-line production. "This is a unique method. The probability of error is minimized, since the human factor is excluded in the testing," the clinic's Director Levan Ratiani told reporters. Recently, Ratiani reported that the clinic received 1 thousand "gin Expert" tests from the United States on April 17.

He noted that with the help of tests "gin Expert" will check suspicious cases only among those patients who need hospitalization.Due to the limited number of cartridges, the test will not be mass-produced; it is used for high-risk and seriously ill patients.

You can diagnose an infection with the help of "Jinexpert" tests in 50 minutes, confirmed the senior laboratory doctor of the clinic Hatia Mikaberidze.

"This GeneXpert device gives you an answer in 50 minutes. Nucleic acids of the virus are detected by catarrhal method. This is an absolutely closed system that allows us to exclude human errors, " Mikaberidze said. Xpert MTB/RIF is a fully automated rapid test based on nucleic acid amplification, which was the first major breakthrough in the diagnosis of tuberculosis after sputum smear microscopy was developed more than 100 years ago, according to the world health organization website.

apsny.ge





Tags:



At the University clinic of Tbilisi used a new ultra-fast us test the system

2020/05/56406-1588322038.jpg
Read: 1210     11:00     01 Май 2020    

The first University clinic in Tbilisi uses new American test systems "GeneXpert" (GeneXpert), the release of which in mid-March was approved by the us food and drug Administration (FDA). GeneExpert test systems are the latest devices for detecting coronavirus within 45 minutes of preparing a sample for analysis. The technology was developed by the California - based company Cepheid. You don't need special training to work with this test system-you only need access to the Cepheid GeneXpert system to process the test results.

The US authorities are confident that the production of such tests is an important step in the fight against the pandemic and are establishing their in-line production. "This is a unique method. The probability of error is minimized, since the human factor is excluded in the testing," the clinic's Director Levan Ratiani told reporters. Recently, Ratiani reported that the clinic received 1 thousand "gin Expert" tests from the United States on April 17.

He noted that with the help of tests "gin Expert" will check suspicious cases only among those patients who need hospitalization.Due to the limited number of cartridges, the test will not be mass-produced; it is used for high-risk and seriously ill patients.

You can diagnose an infection with the help of "Jinexpert" tests in 50 minutes, confirmed the senior laboratory doctor of the clinic Hatia Mikaberidze.

"This GeneXpert device gives you an answer in 50 minutes. Nucleic acids of the virus are detected by catarrhal method. This is an absolutely closed system that allows us to exclude human errors, " Mikaberidze said. Xpert MTB/RIF is a fully automated rapid test based on nucleic acid amplification, which was the first major breakthrough in the diagnosis of tuberculosis after sputum smear microscopy was developed more than 100 years ago, according to the world health organization website.

apsny.ge





Tags: